JW Pharmaceutical Profit Margin

JW Pharmaceutical (001067.KS) currently reports a profit margin of 12.35% as of June 2026. That compares with 7.01% in the prior-year period — up 76.2% year over year. That is below the sector sector average of 13.78%. Use the charts on this page to explore JW Pharmaceutical's profit margin history and peer comparisons.

JW Pharmaceutical's profit margin increased from 7.01% to 12.35% — a 76.2% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

JW Pharmaceutical's profit margin of 12.35% is lower than the its sector sector average of 13.78%. That is roughly 10.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but JW Pharmaceutical's current 12.35% should be judged against industry norms (sector average: 13.78%) and against 001067.KS's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 12.35%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.78%. From there, open related valuation or income-statement pages for JW Pharmaceutical, and consider following 001067.KS for alerts when major investors trade the stock.